Sphere

Sphere EBIT Growth

The Year-over-Year EBIT Growth of Sphere (347700.KQ) as of Oct 20, 2026 is 165.03 %. In the previous year, Year-over-Year EBIT Growth was -49.46 % — a change of -433.65% (higher).

EBIT Growth

165.03 %

YoY

-433.65%

Last updated:

Year-over-Year EBIT Growth of Sphere is 2025 165.03 % . Year-over-Year EBIT Growth of Sphere was 2024 -49.46 % . It decreases by -433.65% higher compared to the previous year.

The Sphere EBIT Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Growth
Date
EBIT Growth
Jan 1, 2018
-219.14 KRW
Jan 1, 2019
-24.82 KRW
Jan 1, 2020
-2.21 KRW
Jan 1, 2021
-65.07 KRW
Jan 1, 2022
7.09 KRW
Jan 1, 2023
-66.03 KRW
Jan 1, 2024
-49.46 KRW
Jan 1, 2025
165.03 KRW
The Sphere EBIT Growth history
YEAREBIT GrowthYoY
165.03 %-433.65%
-49.46 %-25.09%
-66.03 %-1,030.85%
7.09 %-110.90%
-65.07 %+2,847.52%
-2.21 %-91.11%
-24.82 %-88.67%
-219.14 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sphere Stock analysis

What does Sphere do? Sphere Corp, listed under the ticker 347700.KQ and ISIN KR7347700007, is a South Korean health care company headquartered in Seoul. The company went public on March 23, 2021, and currently employs 53 full-time staff. Sphere Corp operates within the health care sector, focusing on digital health technology platforms and solutions. The company's website is https://lifesemantics.kr/, which serves as its primary online presence. Sphere Corp provides a digital health record data platform, enabling personalized health management through technology. The company's offerings include digital health technology platforms and digital health solutions, though specific product names such as LifeRecord, H.AI, OHA, Dr. Call, Redpill care, and Redpill breathtaking are not verified as part of the company's official portfolio. Additionally, Sphere Corp engages in the sale of diagnostic reagents and equipment, though details regarding these products are not elaborated in the provided information. The company's operations are based in Seoul, South Korea, and it is categorized under the health care industry. The information regarding its founding year, key personnel, and specific financial figures is not included in the provided data. Sphere Corp's focus remains on delivering digital health services through its platform, aiming to enhance personalized health care experiences for users. Sphere is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sphere stock

Year-over-Year EBIT Growth of Sphere is 165.03 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year EBIT Growth Sphere since 2006 – with annual values, charts, and detailed analysis.

EBIT growth measures the percentage change in operating earnings. It shows whether a company's core operations are becoming more profitable.

To evaluate Year-over-Year EBIT Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year EBIT Growth.

Year-over-Year EBIT Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year EBIT Growth's Sphere historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Sphere

All Key Metrics — Sphere